1/ In press in @JACCJournals JACC: Heart Failure today:
Endomyocardial Biopsy Characterization of HFpEF and Prevalence of Cardiac Amyloidosis
@KSharmaMD @dkassjhu @lryanek @jvaishnavmd @WendyYingMD @vinisubramanya @EE_Brown42
@Marc_Halushka @RyanTedfordMD @HFpEF @hopkinsheart
Endomyocardial Biopsy Characterization of HFpEF and Prevalence of Cardiac Amyloidosis
@KSharmaMD @dkassjhu @lryanek @jvaishnavmd @WendyYingMD @vinisubramanya @EE_Brown42
@Marc_Halushka @RyanTedfordMD @HFpEF @hopkinsheart
2/ We prospectively enrolled 108 HFpEF pts who underwent RHC + bx and found 14% had amyloid, often unsuspected.
4/ Myocardial CD68+ cells were in non-amyloid #HFpEF vs controls, and associated with older age and renal dysfunction
5/ Consider amyloid workup in #HFpEF pts- particularly older, BP, BMI, hypertrophy, cardiac biomarkers
6/ Tissue-based phenotyping may be the to personalized tx for #HFpEF
Grateful to my mentors @dkassjhu @KSharmaMD @StevenSchulman7 and collaborators!!!
Grateful to my mentors @dkassjhu @KSharmaMD @StevenSchulman7 and collaborators!!!